-
1
-
-
0027529301
-
Modeling receptor-mediated processes with dioxin: Implications for pharmacokinetics and risk assessment
-
Andersen, M.E., Mills, J.J., and Gargas, M.L. (1993) Modeling receptor-mediated processes with dioxin: Implications for pharmacokinetics and risk assessment. Risk Anal., 13, 25-36.
-
(1993)
Risk Anal.
, vol.13
, pp. 25-36
-
-
Andersen, M.E.1
Mills, J.J.2
Gargas, M.L.3
-
2
-
-
33845996187
-
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver
-
Barter, Z.E., Bayliss, M.K., Beaune, P.H., et al. (2007) Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. Current Drug Metabolism, 8 (1), 33-45.
-
(2007)
Current Drug Metabolism
, vol.8
, Issue.1
, pp. 33-45
-
-
Barter, Z.E.1
Bayliss, M.K.2
Beaune, P.H.3
-
3
-
-
18244379659
-
In silico approaches for developing physiologically based pharmacokinetic (PBPK) models
-
(eds H. Salem and S. Katz), CRC Press, NY
-
Béliveau, M. and Krishnan, K. (2003) In silico approaches for developing physiologically based pharmacokinetic (PBPK) models, in Alernative Toxicology Methods (eds H. Salem and S. Katz), CRC Press, NY, pp. 479-532.
-
(2003)
in Alernative Toxicology Methods
, pp. 479-532
-
-
Béliveau, M.1
Krishnan, K.2
-
4
-
-
18244382840
-
A spreadsheet program for modeling quantitative structurepharmacokinetic relationships for inhaled volatile organics in humans
-
Béliveau, M. and Krishnan, K. (2005) A spreadsheet program for modeling quantitative structurepharmacokinetic relationships for inhaled volatile organics in humans. SAR QSAR Environ. Res., 16, 63-77.
-
(2005)
SAR QSAR Environ. Res.
, vol.16
, pp. 63-77
-
-
Béliveau, M.1
Krishnan, K.2
-
5
-
-
15344349015
-
Quantitative structure-property relationships for interspecies extrapolation of the inhalation pharmaconkinetics of organic chemicals
-
Béliveau, M., Lipscomb, J., Tardif, R., and Krishnan, K. (2005) Quantitative structure-property relationships for interspecies extrapolation of the inhalation pharmaconkinetics of organic chemicals. Chem. Res. Toxicol., 18, 475-485.
-
(2005)
Chem. Res. Toxicol.
, vol.18
, pp. 475-485
-
-
Béliveau, M.1
Lipscomb, J.2
Tardif, R.3
Krishnan, K.4
-
6
-
-
0030806348
-
Physiological parameter values for physiologically based pharmacokinetic models
-
Brown, R.P., Delp, M.D., Lindstedt, S.L., et al. (1997) Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health, 13, 407-484.
-
(1997)
Toxicol. Ind. Health
, vol.13
, pp. 407-484
-
-
Brown, R.P.1
Delp, M.D.2
Lindstedt, S.L.3
-
7
-
-
34247510787
-
Evaluation of physiologically based pharmacokinetic models for use in risk assessment
-
Chiu, W.A., Barton, H.A., and Dewoskin, R.S. (2007) Evaluation of physiologically based pharmacokinetic models for use in risk assessment. Journal of Applied Toxicology, 27, 218-237.
-
(2007)
Journal of Applied Toxicology
, vol.27
, pp. 218-237
-
-
Chiu, W.A.1
Barton, H.A.2
Dewoskin, R.S.3
-
8
-
-
11344264355
-
Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment
-
Clark, L.H., Setzer,R.W., and Barton, H.A. (2004) Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment. Risk Anal., 24, 1697-1717.
-
(2004)
Risk Anal.
, vol.24
, pp. 1697-1717
-
-
Clark, L.H.1
Setzer, R.W.2
Barton, H.A.3
-
9
-
-
0036151312
-
A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment
-
Clewell, H.J., Andersen, M.E., and Barton, H.A. (2002) A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment. Environmental Health Perspectives, 110, 85-93.
-
(2002)
Environmental Health Perspectives
, vol.110
, pp. 85-93
-
-
Clewell, H.J.1
Andersen, M.E.2
Barton, H.A.3
-
10
-
-
37549042390
-
Development and specification of physiologically based pharmacokinetic models for use in risk assessment
-
3rd
-
Clewell, R.A., Clewell, H.J. 3rd (2008) Development and specification of physiologically based pharmacokinetic models for use in risk assessment. Regulatory Toxicology and Pharmacology, 50 (1), 129-143.
-
(2008)
Regulatory Toxicology and Pharmacology
, vol.50
, Issue.1
, pp. 129-143
-
-
Clewell, R.A.1
Clewell, H.J.2
-
11
-
-
0037452416
-
Atoxicokinetic model for styrene and its metabolite styrene-7,8-oxide in mouse, rat and human with special emphasis on the lung
-
Csanady, G.A., Kessler,W., Hoffmann H.D., and Filser, J.G. (2003)Atoxicokinetic model for styrene and its metabolite styrene-7,8-oxide in mouse, rat and human with special emphasis on the lung. Toxicol. Lett., 138, 75-102.
-
(2003)
Toxicol. Lett.
, vol.138
, pp. 75-102
-
-
Csanady, G.A.1
Kessler, W.2
Hoffmann, H.D.3
Filser, J.G.4
-
12
-
-
0030605039
-
A physiological toxicokinetic model for 1,3-butadiene in rodents and man: blood concentrations of 1,3-butadiene, its metabolically formed epoxides, and of haemoglobin adducts-relevance of glutathione depletion
-
Csanady, G.A., Kreuzer, P.E., Baur, C., and Filser, J.G. (1996) A physiological toxicokinetic model for 1,3-butadiene in rodents and man: blood concentrations of 1,3-butadiene, its metabolically formed epoxides, and of haemoglobin adducts-relevance of glutathione depletion. Toxicology, 113, 300-305.
-
(1996)
Toxicology
, vol.113
, pp. 300-305
-
-
Csanady, G.A.1
Kreuzer, P.E.2
Baur, C.3
Filser, J.G.4
-
13
-
-
0023916058
-
Physiological model for tissue glutathione depletion and decreased resynthesis after ethylene dichloride exposures
-
D'Souza, R.W., Francis,W.R., and Andersen,M.W. (1988) Physiological model for tissue glutathione depletion and decreased resynthesis after ethylene dichloride exposures. J. Pharmacol. Exp. Ther., 245, 563-568.
-
(1988)
J. Pharmacol. Exp. Ther.
, vol.245
, pp. 563-568
-
-
D'Souza, R.W.1
Francis, W.R.2
Andersen, M.W.3
-
14
-
-
0012785645
-
Mathematical modeling of inhalation exposure
-
Fiserova-Bergerova, V. (1975) Mathematical modeling of inhalation exposure. J. Combust. Toxicol., 32, 201-210.
-
(1975)
J. Combust. Toxicol.
, vol.32
, pp. 201-210
-
-
Fiserova-Bergerova, V.1
-
15
-
-
84886025629
-
Numerical Initial Value Problems in Ordinary Differential Equations, Prentice- Hall, Englewoods Cliffs, NJ
-
Gear, C.W. (1971) Numerical Initial Value Problems in Ordinary Differential Equations, Prentice- Hall, Englewoods Cliffs, NJ. Gerlowski, L.E. and Jain, R.K. (1983) Physiologically based pharmacokinetic modeling: principles and applications. Journal of Pharmaceutical Sciences, 72, 1103-1127.
-
(1971)
Gerlowski, L.E. and Jain, R.K. (1983) Physiologically based pharmacokinetic modeling: principles and applications. Journal of Pharmaceutical Sciences
, vol.72
, pp. 1103-1127
-
-
Gear, C.W.1
-
16
-
-
0029871040
-
A methodology for solving physiologically based pharmacokinetic models without the use of simulation softwares
-
Haddad, S., Pelekis, M., and Krishnan, K. (1996) A methodology for solving physiologically based pharmacokinetic models without the use of simulation softwares. Toxicol. Lett., 85, 113-126.
-
(1996)
Toxicol. Lett.
, vol.85
, pp. 113-126
-
-
Haddad, S.1
Pelekis, M.2
Krishnan, K.3
-
18
-
-
84885997477
-
-
G. Fischer), VCH Publishers, Stuttgart/New York. Himmelstein,M.W., Carpenter, S.C., Evans,M.V., et al. (2004) Kinetic modeling of beta-chloroprene metabolism: II. The application of physiologically based modeling for cancer dose response analysis. Toxicol. Sci.
-
Heinzel, G.,Woloszczak, R., and Thomann, P. (1993) TopFit, Version 2.0: Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC (ed. G. Fischer), VCH Publishers, Stuttgart/New York. Himmelstein,M.W., Carpenter, S.C., Evans,M.V., et al. (2004) Kinetic modeling of beta-chloroprene metabolism: II. The application of physiologically based modeling for cancer dose response analysis. Toxicol. Sci., 79, 28-37.
-
(1993)
TopFit, Version 2.0: Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC (ed
, vol.79
, pp. 28-37
-
-
Heinzel, G.1
Woloszczak, R.2
Thomann, P.3
-
19
-
-
0028342648
-
Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance
-
Houston, J.B. (1994) Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem. Pharmacol., 47, 1469-1479.
-
(1994)
Biochem. Pharmacol.
, vol.47
, pp. 1469-1479
-
-
Houston, J.B.1
-
20
-
-
0025666559
-
Interspecies scaling and comparisons in drug development and toxicokinetics
-
Ings, R.M.J. (1990) Interspecies scaling and comparisons in drug development and toxicokinetics. Xenobiotica, 20, 1201-1231.
-
(1990)
Xenobiotica
, vol.20
, pp. 1201-1231
-
-
Ings, R.M.J.1
-
21
-
-
0035951611
-
Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene
-
Jonsson, F. and Johanson, G. (2001) Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene. Toxicology, 157, 177-193.
-
(2001)
Toxicology
, vol.157
, pp. 177-193
-
-
Jonsson, F.1
Johanson, G.2
-
22
-
-
57349189517
-
An integrated QSPR-PBPK modelling approach for in vitro-in vivo extrapolation of pharmacokinetics in rats
-
Kamgang, E., Peyret, T., and Krishnan, K. (2008) An integrated QSPR-PBPK modelling approach for in vitro-in vivo extrapolation of pharmacokinetics in rats. SAR QSAR Environ. Res., 19, 669-680.
-
(2008)
SAR QSAR Environ. Res.
, vol.19
, pp. 669-680
-
-
Kamgang, E.1
Peyret, T.2
Krishnan, K.3
-
23
-
-
44349129408
-
The theory and application of the exchange of inert gas at the lungs
-
Kety, S.S. (1951) The theory and application of the exchange of inert gas at the lungs. Pharmacol. Rev., 3, 1-41.
-
(1951)
Pharmacol. Rev.
, vol.3
, pp. 1-41
-
-
Kety, S.S.1
-
24
-
-
0002252722
-
Physiologically based pharmacokinetic modeling in toxicology
-
(ed. A.W. Hayes), Raven Press Ltd, New York
-
Krishnan, K. and Andersen, M.E. (1994) Physiologically based pharmacokinetic modeling in toxicology, in Principals and Methods of Toxicology (ed. A.W. Hayes), Raven Press Ltd., New York, pp. 149-188.
-
(1994)
in Principals and Methods of Toxicology
, pp. 149-188
-
-
Krishnan, K.1
Andersen, M.E.2
-
25
-
-
0000581605
-
Physiologically based pharmacokinetic modeling in toxicology
-
(ed. A.W. Hayes), Taylor and Francis, Philadelphia, PA
-
Krishnan, K. and Andersen, M.E. (2001) Physiologically based pharmacokinetic modeling in toxicology, in Principles and Methods of Toxicology (ed. A.W. Hayes), Taylor & Francis, Philadelphia, PA, pp. 193-241.
-
(2001)
in Principles and Methods of Toxicology
, pp. 193-241
-
-
Krishnan, K.1
Andersen, M.E.2
-
26
-
-
0000581605
-
Physiologically based pharmacokinetic modeling in toxicology
-
(ed. A.W. Hayes), Taylor and Francis, New York
-
Krishnan, K. and Andersen, M.E. (2007) Physiologically based pharmacokinetic modeling in toxicology, in Principles and Methods of Toxicology (ed. A.W. Hayes), Taylor & Francis, New York, pp. 193-241.
-
(2007)
in Principles and Methods of Toxicology
, pp. 193-241
-
-
Krishnan, K.1
Andersen, M.E.2
-
27
-
-
0026653651
-
A physiologically-based description of ethylene oxide dosimetry in the rat
-
Krishnan, K., Gargas, M.L., Fennell, T.R., and Andersen, M.E. (1992) A physiologically-based description of ethylene oxide dosimetry in the rat. Toxicol. Ind. Health, 8, 121-140.
-
(1992)
Toxicol. Ind. Health
, vol.8
, pp. 121-140
-
-
Krishnan, K.1
Gargas, M.L.2
Fennell, T.R.3
Andersen, M.E.4
-
28
-
-
1042274085
-
-
Kluwer Academic/Plenum Publishers, New York Lipscomb, J.C. and Ohanian, E.V. (eds.) (2006) Toxicokinetics and Risk Assessment, Informa Healthcare, New York, NY, 361 pp. Lipscomb, J.C. and Poet, T.S. (2008) In vitro measurements of metabolism for application in pharmacokinetic modeling. Pharmacology and Therapeutics
-
Kwon, Y. (2001) Handbook of Essential Pharmacokinetics, Pharmacodynamics, and Drug Metabolism for Industrial Scientists, Kluwer Academic/Plenum Publishers, New York. Lipscomb, J.C. and Ohanian, E.V. (eds.) (2006) Toxicokinetics and Risk Assessment, Informa Healthcare, New York, NY, 361 pp. Lipscomb, J.C. and Poet, T.S. (2008) In vitro measurements of metabolism for application in pharmacokinetic modeling. Pharmacology and Therapeutics, 118, 82-103.
-
(2001)
Handbook of Essential Pharmacokinetics, Pharmacodynamics, and Drug Metabolism for Industrial Scientists
, vol.118
, pp. 82-103
-
-
Kwon, Y.1
-
29
-
-
0345791469
-
The Impact of Cytochrome P450 2E1- dependent Metabolic Variance on a Risk Relevant Pharmacokinetic Outcome in Humans
-
Lipscomb, J.C., Teuschler, L.K., Swartout, J., et al. (2003) The Impact of Cytochrome P450 2E1- dependent Metabolic Variance on a Risk Relevant Pharmacokinetic Outcome in Humans. Risk Analysis, 23, 1221-1238.
-
(2003)
Risk Analysis
, vol.23
, pp. 1221-1238
-
-
Lipscomb, J.C.1
Teuschler, L.K.2
Swartout, J.3
-
30
-
-
1642523389
-
The metabolic rate constants and specific activity of human and rat cytochrome P450 2E1 toward chloroform
-
Lipscomb, J.C., Barton, H., Tornero-Velez, R., et al. (2004) The metabolic rate constants and specific activity of human and rat cytochrome P450 2E1 toward chloroform. J. Toxicol. Envtl. Hlth. (Part A), 67, 537-553.
-
(2004)
J. Toxicol. Envtl. Hlth. (Part A)
, vol.67
, pp. 537-553
-
-
Lipscomb, J.C.1
Barton, H.2
Tornero-Velez, R.3
-
31
-
-
33750183365
-
An integrated approach to model hepatic drug clearance
-
Liu, L. and Pang, K.S. (2006) An integrated approach to model hepatic drug clearance. Eur. J. Pharm. Sci., 29, 215-230.
-
(2006)
Eur. J. Pharm. Sci.
, vol.29
, pp. 215-230
-
-
Liu, L.1
Pang, K.S.2
-
32
-
-
0001015241
-
An electric analog for uptake and elimination in man
-
Mapleson, W.W. (1963) An electric analog for uptake and elimination in man. J. Appl. Physiol., 18, 197-204.
-
(1963)
J. Appl. Physiol.
, vol.18
, pp. 197-204
-
-
Mapleson, W.W.1
-
33
-
-
34250639000
-
In vitro metabolism of the fungicide and environmental contaminant trans-bromuconazole and implications for risk assessment
-
Mazur, C.S., Kenneke, J.F., Tebes-Stevens, C., et al. (2007) In vitro metabolism of the fungicide and environmental contaminant trans-bromuconazole and implications for risk assessment. J. Toxicol. Envtl. Health, 70, 1241-1250.
-
(2007)
J. Toxicol. Envtl. Health
, vol.70
, pp. 1241-1250
-
-
Mazur, C.S.1
Kenneke, J.F.2
Tebes-Stevens, C.3
-
34
-
-
84886052279
-
-
Poulin, P. and Krishnan, K. (1995) An algorithm for predicting tissue: blood partition coefficients of organic chemicals from n-octanol: water partition coefficient data. J. Toxicol. Environ. Health
-
Notari, R.E. (1987) Biopharmaceutics and Clinical Pharmacokinetics: An Introduction, Marcel Dekker, New York. Poulin, P. and Krishnan, K. (1995) An algorithm for predicting tissue: blood partition coefficients of organic chemicals from n-octanol: water partition coefficient data. J. Toxicol. Environ. Health, 46, 117-129.
-
(1987)
Biopharmaceutics and Clinical Pharmacokinetics: An Introduction, Marcel Dekker, New York
, vol.46
, pp. 117-129
-
-
Notari, R.E.1
-
35
-
-
0033966128
-
A priori prediction of tissue: plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery
-
Poulin, P. and Theil, F.P. (2000) A priori prediction of tissue: plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. J. Pharm. Sci., 89, 16-35.
-
(2000)
J. Pharm. Sci.
, vol.89
, pp. 16-35
-
-
Poulin, P.1
Theil, F.P.2
-
36
-
-
0036144815
-
Prediction of pharmacokinetics prior to in vivo studies 1.Mechanismbased prediction of volume of distribution
-
Poulin, P. and Theil, F.P. (2002) Prediction of pharmacokinetics prior to in vivo studies. 1.Mechanismbased prediction of volume of distribution. J. Pharm. Sci., 91, 129-156.
-
(2002)
J. Pharm. Sci.
, vol.91
, pp. 129-156
-
-
Poulin, P.1
Theil, F.P.2
-
37
-
-
0000900027
-
Mechanistic animal replacement approaches for predicting pharmacokinetics of organic chemicals
-
(eds H. Salem and S.A. Katz), Humana Press Inc., Totowa, NJ
-
Poulin, P., Beliveau, M., and Krishnan, K. (1999) Mechanistic animal replacement approaches for predicting pharmacokinetics of organic chemicals, in Toxicity Assessment alternatives: Methods, Issues, Opportunities (eds H. Salem and S.A. Katz), Humana Press Inc., Totowa, NJ, pp. 115- 139.
-
(1999)
in Toxicity Assessment alternatives: Methods, Issues, Opportunities
, pp. 115-139
-
-
Poulin, P.1
Beliveau, M.2
Krishnan, K.3
-
38
-
-
0021279862
-
A physiologically-based description of the inhalation pharmacokinetics of styrene in rats and humans
-
Ramsey, J.C. and Andersen, M.E. (1984) A physiologically-based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol., 73, 159-175.
-
(1984)
Toxicol. Appl. Pharmacol.
, vol.73
, pp. 159-175
-
-
Ramsey, J.C.1
Andersen, M.E.2
-
39
-
-
84890762143
-
-
John Wiley & Sons, Inc., New Jersey.
-
Reddy, M., Yang, R.S., Clewell, H.J. III and Andersen, M.E. (2005) Physiologically Based Pharmacokinetic Modeling: Science and Applications. John Wiley & Sons, Inc., New Jersey.
-
(2005)
Physiologically Based Pharmacokinetic Modeling: Science and Applications
, vol.46
, pp. 559-566
-
-
Reddy, M.1
Yang, R.S.2
Clewell, H.J.3
Andersen, M.E.4
-
40
-
-
0027242397
-
Validation and use of cloned, expressed human drugmetabolizing enzymes in heterologous cells for analysis of drug metabolism and drug-drug interactions
-
Remmel, R.P. and Burchell, B. (1993) Validation and use of cloned, expressed human drugmetabolizing enzymes in heterologous cells for analysis of drug metabolism and drug-drug interactions. Biochem. Pharmacol., 46, 559-566.
-
(1993)
Biochem. Pharmacol.
, vol.46
, pp. 559-566
-
-
Remmel, R.P.1
Burchell, B.2
-
43
-
-
21344469211
-
Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases
-
Rodgers, T., Leahy, D., and Rowland, M. (2005) Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. J. Pharm. Sci., 94, 1259-1276.
-
(2005)
J. Pharm. Sci.
, vol.94
, pp. 1259-1276
-
-
Rodgers, T.1
Leahy, D.2
Rowland, M.3
-
44
-
-
33745055239
-
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
-
Rodgers, T. and Rowland, M. (2006) Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. J. Pharm. Sci., 95, 1238-1257.
-
(2006)
J. Pharm. Sci.
, vol.95
, pp. 1238-1257
-
-
Rodgers, T.1
Rowland, M.2
-
46
-
-
0028237729
-
Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japaneses and 30 Caucasions
-
Shimada, T., Yamazaki, H., Mimura, M., et al. (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japaneses and 30 Caucasions. J. Pharmacol. Exp. Ther., 270, 414-423.
-
(1994)
J. Pharmacol. Exp. Ther.
, vol.270
, pp. 414-423
-
-
Shimada, T.1
Yamazaki, H.2
Mimura, M.3
-
47
-
-
0033743267
-
Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk assessment
-
Snawder, J.E. and Lipscomb, J.C. (2000) Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk assessment. Regul. Toxicol. Pharmacol., 32, 200-209.
-
(2000)
Regul. Toxicol. Pharmacol.
, vol.32
, pp. 200-209
-
-
Snawder, J.E.1
Lipscomb, J.C.2
-
48
-
-
0001146538
-
Kinetics of distribution of substances administered to the body. I. The extravascular modes of administration
-
Teorell, T. (1937a)Kinetics of distribution of substances administered to the body. I. The extravascular modes of administration. Arch. Int. Pharmacodyn., 57, 205-225.
-
(1937)
Arch. Int. Pharmacodyn
, vol.57
, pp. 205-225
-
-
Teorell, T.1
-
49
-
-
0001146538
-
Kinetics of distribution of substances administered to the body. II. The intravascular modes of administration
-
Teorell, T. (1937b) Kinetics of distribution of substances administered to the body. II. The intravascular modes of administration. Arch. Int. Pharmacodyn., 57, 226-240.
-
(1937)
Arch. Int. Pharmacodyn
, vol.57
, pp. 226-240
-
-
Teorell, T.1
-
50
-
-
84885964591
-
-
USEPA (United States Environmental Protection Agency) (2005) Use of Physiologically Based Pharmacokinetic Models to Quantify the Impact of Human Age and Interindividual Differences in Physiology and Biochemistry Pertinent to Risk: Final Report for Cooperative Agreement. EPA 600/R-06-014A. USEPA (United States Environmental Protection Agency) Approaches for the application of physiologically based pharmacokinetic (PBPK) models and supporting data in risk assessment. EPA 600/R-05/043A.
-
USEPA (United States Environmental Protection Agency) (2005) Use of Physiologically Based Pharmacokinetic Models to Quantify the Impact of Human Age and Interindividual Differences in Physiology and Biochemistry Pertinent to Risk: Final Report for Cooperative Agreement. EPA 600/R-06-014A. USEPA (United States Environmental Protection Agency) (2006) Approaches for the application of physiologically based pharmacokinetic (PBPK) models and supporting data in risk assessment. EPA 600/R-05/043A.
-
(2006)
-
-
|